rs878854355
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PM2PP3_ModeratePP5
The NM_001017980.4(VMA21):c.*6A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001017980.4 3_prime_UTR
Scores
Clinical Significance
Conservation
Publications
- X-linked myopathy with excessive autophagyInheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VMA21 | ENST00000330374.7 | c.*6A>G | 3_prime_UTR_variant | Exon 3 of 3 | 1 | NM_001017980.4 | ENSP00000333255.6 | |||
VMA21 | ENST00000477649.1 | n.392A>G | non_coding_transcript_exon_variant | Exon 3 of 3 | 3 | |||||
VMA21 | ENST00000370361.5 | c.*6A>G | 3_prime_UTR_variant | Exon 4 of 4 | 5 | ENSP00000359386.1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
X-linked myopathy with excessive autophagy Pathogenic:2
This variant occurs in a non-coding region of the VMA21 gene. It does not change the encoded amino acid sequence of the VMA21 protein. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individuals with X-linked myopathy with excessive autophagy (XMEA) (PMID: 23315026). ClinVar contains an entry for this variant (Variation ID: 208803). Algorithms developed to predict the effect of variants on gene product structure and function are not available or were not evaluated for this variant. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on VMA21 function (PMID: 23315026). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. For these reasons, this variant has been classified as Pathogenic. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at